06/14/2021
New approaches to manage the asthmatic lung, allergic skin, and array of other allergic conditions include therapies targeting key cells and mediators driving the inflammatory responses. These are subcutaneous injections that are administered between every two and eight weeks in office.
Learn more!
https://qoo.ly/3cp4yn